-
Mashup Score: 0Psilocybin Poison Control Calls Spike in Teens, Young Adults - 13 day(s) ago
Legalization efforts have been for adults aged 21 years and older so the rise in use in younger people is especially concerning.
Source: www.mdedge.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 18Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations - 4 month(s) ago
McTaggart et al. compare impacts of domestication and naturalization in magic mushrooms (Psilocybe cubensis). Domesticated cultivars have few founders, highly homozygous genomes, and low allelic diversity caused by inbreeding. Naturalized populations in Australia maintained genetic diversity and have unique alleles for psilocybin production.
Source: www.cell.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 16Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations - 4 month(s) ago
McTaggart et al. compare impacts of domestication and naturalization in magic mushrooms (Psilocybe cubensis). Domesticated cultivars have few founders, highly homozygous genomes, and low allelic diversity caused by inbreeding. Naturalized populations in Australia maintained genetic diversity and have unique alleles for psilocybin production.
Source: www.cell.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Psilocybin - The ASCO Post - 6 month(s) ago
The ASCO Post’s Integrative Oncology series is intended to facilitate the availability of evidence-based information on integrative and complementary therapies sometimes used by patients with cancer. In this installment, Yen Nien (Jason) Hou, PharmD, DiplOM, LAc, and Jyothirmai Gubili, MS, focus on the use of psilocybin—a naturally occurring psychedelic prodrug compound—given the growing interest in its use for mood disorders. Yen Nien (Jason) Hou, PharmD, DiplOM, LAc Common Names: Magic mushrooms,
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy - 6 month(s) ago
The country is the first to make psilocybin and MDMA available for medical use by prescription as part of a psychedelic-assisted psychotherapy regimen.
Source: psychnews.psychiatryonline.orgCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 0BP Targets After Stroke Thrombectomy, Psilocybin for Depression, Large Language Models in Medicine, and more - 7 month(s) ago
Editor’s Summary by Anthony Charles, MD, MPH, Associate Editor of JAMA, the Journal of the American Medical Association, for the September 5, 2023, issue.
Source: edhub.ama-assn.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 24Single-Dose Psilocybin Treatment for Major Depressive Disorder - 7 month(s) ago
This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients with major depressive disorder compared with placebo.
Source: jamanetwork.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 58Single-Dose Psilocybin Treatment for Major Depressive Disorder - 7 month(s) ago
This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients with major depressive disorder compared with placebo.
Source: jamanetwork.comCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 4
Women with gynecologic cancers face various physical and psychological challenges throughout their treatment journey. Late stages associated with poor prognosis, along with chronic side effects of treatment, often leave women with existential uncertainty stemming from unpredictable disease
Source: ijgc.bmj.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 2Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy - 7 month(s) ago
The country is the first to make psilocybin and MDMA available for medical use by prescription as part of a psychedelic-assisted psychotherapy regimen.
Source: psychnews.psychiatryonline.orgCategories: Latest Headlines, PsychiatryTweet
Calls to US poison centers related to #psilocybin more than tripled among teens and more than doubled in young adults. https://t.co/5m1ESDsPIH https://t.co/7EmwREp9op